Si-Bone (SIBN) Debt to Equity (2017 - 2026)
Si-Bone's quarterly Debt to Equity came in at $0.2 in Q1 2026, down 6.22% year-on-year from $0.21 in Q1 2025, and down 0.7% quarter-over-quarter from $0.2 in Q4 2025.
Si-Bone has reported Debt to Equity for 10 years, with the latest figure at $0.2 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 6.22% year-over-year to $0.2; the trailing twelve-month figure through Mar 2026 stood at $0.2 (down 6.22% YoY), and the FY2025 full-year result was $0.2, down 5.64% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.2, down from $0.2 in the prior quarter.
- The five-year high for Debt to Equity was $0.38 in Q1 2023, with the low at $0.2 in Q1 2026.
- Average Debt to Equity over 5 years is $0.25, with a median of $0.21 recorded in 2023.
- Year-over-year, Debt to Equity jumped 40.48% in 2022 and slumped 42.97% in 2024.
- Tracing SIBN's Debt to Equity over 5 years: stood at $0.36 in 2022, then plunged by 40.49% to $0.21 in 2023, then retreated by 0.28% to $0.21 in 2024, then fell by 5.64% to $0.2 in 2025, then decreased by 0.7% to $0.2 in 2026.
- The last three Debt to Equity figures came in at $0.2 (Q1 2026), $0.2 (Q4 2025), and $0.21 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.22 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.26 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.26 |
| Mar 31, 2021 | 0.24 |
| Dec 31, 2020 | 0.23 |
| Sep 30, 2020 | 0.39 |
| Jun 30, 2020 | 0.36 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.62 |
| Sep 30, 2019 | 0.57 |
| Jun 30, 2019 | 0.50 |
| Mar 31, 2019 | 0.47 |
| Dec 31, 2018 | 0.43 |
| Sep 30, 2018 | -0.28 |
| Dec 31, 2017 | -0.30 |